Treating reactive arthritis: Insights for the clinician

Therapeutic Advances in Musculoskeletal Disease

Volumn 2, Issue 1, 2010, Pages 45-54

  Carter, John D ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

drug therapy; reactive arthritis; Reiter s syndrome; spondyloarthritis

Indexed keywords

EID: 84993812009     PISSN: 1759720X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1759720X09357508     Document Type: Review

References (59)

1. Barth, W.F. and Segal, K. ( 1999) Reactive arthritis (Reiter's syndrome). Am Fam Physician 60: 499-503.
2. Birnbaum, J., Bartlett, J.G. and Gelber, A.C. ( 2008) Clostridium difficile: an under-recognized cause of reactive arthritis? Clin Rheumatol 27: 253-255.
3. Braun, J., Laitko, S., Treharne, J., Eggens, U., Wu, P., Distler, A. et al. (1994) Chlamydia pneumoniae - a new causitive agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 53: 100-105.
4. Braun, J., Tuszewski, M., Eggens, U., Mertz, A., Schauer-Petrowskaja, C., Döring, E. et al. (1997) Nested polymerase chain reaction strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol 24: 1092-1100.
5. Braun, J., Yin, Z., Spiller, I., Siegert, S., Rudwaleit, M., Liu, L. et al. (1999) Low secretion of tumor necrosis factor alpha, but no other Th 1 or Th 2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 42: 2039-2044.
6. Carter, J.D. ( 2006) Reactive arthritis: defined etiologies, emerging pathophysiology, and elusive treatment. Infect Dis Clin North Am 20: 827-847.
7. Carter, J.D. and Hudson, A.P. (2009) Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am 35: 21-44.
8. Carter, J.D., Valeriano, J. and Vasey, F.B. ( 2004) A prospective, randomized 9-month comparison of doxycycline vs. doxycycline and rifampin in undifferentiated spondyloarthritis - with special reference to Chlamydia-induced arthritis. J Rheumatol 31: 1973-1980.
9. Carter, J.D., Gerard, H.C. and Hudson, A.P. ( 2008) Psoriasiform lesions induced by tumor necrosis factor antagonists: a skin-deep medical conundrum. Ann Rheum Dis 67: 1181-1183.
10. Carter, J.D., Gérard, H.C., Espinoza, L.R., Ricca, L.R., Valeriano, J., Snelgrove, J. et al. (2009) Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 60: 1311-1316.
11. Clegg, D.O., Reda, D.J., Weisman, M.H., Cush, J.J., Vasey, F.B., Schumacher Jr, H.R. et al. (1996) Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39: 2021-2027.
12. Cuvelier, C., Barbatis, C., Mielants, H., de Vos, M., Roels, H. and Veys, E. ( 1987) Histopathology of intestinal inflammation related to reactive arthritis. Gut 28: 394-401.
13. Doran, M.F., Pond, G.R., Crowson, C.S., O'Fallon, W.M. and Gabriel, S.E. ( 2002) Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46: 625-631.
14. Dreses-Werringloer, U., Padubrin, I., Jurgens-Saathoff, B., Hudson, A.P., Zeidler, H. and Kohler, L. ( 2000) Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 44: 3288-3297.
15. Dreses-Werringloer, U., Padubrin, I., Zeidler, H. and Kohler, L. ( 2001) Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 45: 3001-3008.
16. Dulphy, N., Peyrat, M.A., Tieng, V., Douay, C., Rabian, C., Tamouza, R. et al. (1999) Common intra-articular T cell expansions in patients with reactive arthritis: identical beta-chain junctional sequences and cytotoxicity toward HLA-B27. J Immunol 162: 3830-3839.
17. Egsmose, C., Hansen, T.M., Andersen, L.S., Beier, J.M., Christensen, L., Ejstrup, L. et al. (1997) Limited effect of sulfasalazine treatment in reactive arthritis. A randomized double blind placebo controlled trial. Ann Rheum Dis 56: 32-36.
18. Engel, J.N., Pollack, J., Perara, E. and Ganem, D. ( 1990) Heat shock response of murine Chlamydia trachomatis. J Bacteriol 172: 6959-6972.
19. Flagg, S.D., Meador, R., Hsia, E., Kitumnuaypong, T. and Schumacher Jr, H.R. ( 2005) Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthritis Rheum 53: 613-617.
20. Flores, D., Marquez, J., Garza, M. and Espinoza, L.R. ( 2003) Reactive arthritis: newer developments. Rheum Dis Clin North Am 29: 37-59.
21. Ford, D.H. ( 1987) One syndrome - many infectious agents. J Rheumatol 14: 650-652.
22. Gaston, J.S., Cox, C. and Granfors, K. ( 1999) Clinical and experimental evidence for persistent Yersinia infection in reactive arthritis. Arthritis Rheum 42: 2239-2242.
23. Gerard, H.C., Branigan, P.J., Schumacher Jr, H.R. and Hudson, A.P. ( 1998) Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 25: 734-742.
24. Gerard, H.C., Schumacher, H.R., El-Gabalawy, H., Goldbach-Mansky, R. and Hudson, A.P. ( 2000) Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microb Pathog 29: 17-24.
25. Gerard, H.C., Wang, Z., Whittum-Hudson, J.A., El-Gabalawy, H., Goldbach-Mansky, R., Bardin, T. et al. (2002) Cytokine and chemokine mRNA produced in synovial tissue chronically infected with Chlamydia trachomatis and C. pneumoniae. J Rheumatol 29: 1827-1835.
26. Gerard, H.C., Whittum-Hudson, J.A., Schumacher, H.R. and Hudson, A.P. ( 2004) Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb Pathog 36: 35-39.
27. Granfors, K., Jalkanen, S., Toivanen, P., Koski, J. and Lindberg, A.A. ( 1992) Bacterial lipopolysaccharide in synovial fluid cells in Shigella triggered reactive arthritis. J Rheumatol 19: 500.
28. Groseclose, S.L., Zaidi, A.A., Delisle, S.J., Levine, W.C. and St Louis, M.E. ( 1999) Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 26: 339-344.
29. Haibel, H., Brandt, J. and Rudawaleit, M. ( 2003) Therapy of chronic enteral reactive arthritis with infliximab [abstract]. Ann Rheum Dis 62: AB 0380 [abstract].
30. Hannu, T., Puolakkainen, M. and Leirisalo-Repo, M. ( 1999) Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxford) 38: 411-414.
31. Horowitz, S., Horowitz, J., Taylor-Robinson, D., Sukenik, S., Apte, R.N., Bar-David, J. et al. (1994) Ureaplasma urealyticum in Reiter's Syndrome. J Rheumatol 21: 877-882.
32. Ishihara, T., Aga, M., Hino, K., Ushio, C., Taniguchi, M., Iwaki, K. et al. (2005) Inhibition of Chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha. Biomed Res 26: 179-185.
33. Juvakowski, T. and Lassus, A. ( 1982) A doubleclind cross-over evaluation of ketoprofen and indomethacin in Reiter's disease. Scand J Rheumatol 11: 106-108.
34. Kvien, T.K., Gaston, J.S., Bardin, T., Butrimiene, I., Dijkmans, B.A., Leirisalo-Repo, M. et al. (2004) Three-month treatment of reactive arthritis with azithromycin: A EULAR double-blind, placebo-controlled study. Ann Rheum Dis 63: 1113-1119.
35. Lassus, A. ( 1976) A comparative pilot study of azapropazone and indomethacin in the treatment of psoriatic arthritis and Reiter's disease. Curr Med Res Opin 4: 65-69.
36. Lauhio, A., Leirisalo-Repo, M., Lahdevirta, J., Saikku, P. and Repo, H. ( 1991) Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 34: 6-14.
37. Lu, D.W. and Katz, K.A. ( 2005) Declining use of the eponym ‘Reiter's Syndrome’ in the medical literature, 1998-2003. J Am Acad Dermatol 53: 720-723.
38. Melby, K.K., Kvien, T.K. and Glennas, A. ( 1999) Helicobacter pylori - a trigger of reactive arthritis ? Infection 27: 252-255.
39. Nikkari, S., Rantakokko, K., Ekman, P., Mottonen, T., Leirisalo-Repo, M., Virtala, M. et al. (1999) Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas-chromatography-mass spectrometry in the detection of bacterial components from synovial fluid. Arthritis Rheum 42: 84-89.
40. Oili, K.S., Niinisalo, H., Korpilahde, T. and Virolainen, J. ( 2003) Treatment of reactive arthritis with infliximab. Scand J Rheumatol 32: 122-124.
41. Olivieri, I., van Tubergen, A., Salvarani, C. and van der Linden, S. (2002) Seronegative spondyloarthritides. Best Pract Res Clin Rheumatol 16: 723-739.
42. Panush, R.S., Wallace, D.J., Dorff, R.E. and Engleman, E.P. ( 2007) Retraction of the suggestion to use the term ‘Reiter's syndrome’ sixty-five years later: the legacy of Reiter, a war criminal, should not be eponymic honor but rather condemnation. Arthritis Rheum 56: 693-694.
43. Perry, L.L., Feilzer, K. and Caldwell, H.D. ( 1997) Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and- independent pathways. J Immunol 158: 3344-3352.
44. Rich, E., Hook 3rd, E.W., Alarcon, G.S. and Moreland, L.W. ( 1996) Reactive arthritis in patients attending an urban sexually transmitted disease clinic. Arthritis Rheum 39: 1172-1177.
45. Rihl, M., Gu, J., Baeten, D., Marker-Hermann, E., Goodall, J.C., Gaston, J.S. et al. (2004) Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active
46. transcription of tumour necrosis factor alpha and interferon gamma. Ann Rheum Dis 63: 1673-1676.
47. Sadowski, T. and Steinmeyer, J. ( 2001) Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes. J Rheumatol 28: 336-340.
48. Schrafranski, M.D. ( 2009) Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatol Int May 23 [epub ahead of print].
49. Sieper, J., Fendler, C., Laitko, S., Sorensen, H., Gripenberg-Lerche, C., Hiepe, F. et al. (1999) No benefit of long-term ciprofloxacin in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum 42: 1386-1396.
50. Smieja, M., MacPherson, D.W., Kean, W., Schmuck, M.L., Goldsmith, C.H., Buchanan, W. et al. (2001) Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis. Ann Rheum Dis 60: 1088-1094.
51. Takano, R., Yamaguchi, H., Sugimoto, S., Nakamura, S., Friedman, H. and Yamamoto, Y. ( 2005) Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae. Curr Microbiol 50: 160-166.
52. Thiel, A., Wu, P., Lauster, R., Braun, J., Radbruch, A. and Sieper, J. ( 2000) Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry. Arthritis Rheum 43: 2834-2842.
53. Tinazzi, E., Ficarra, V., Simeoni, S., Artibani, W. and Lunardi, C. ( 2006) Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review. Rheumatol Int 26: 481-488.
54. Townes, J.M., Deodhar, A.A., Laine, E.S., Smith, K., Krug, H.E., Barkhuizen, A. et al. (2008) Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Ann Rheum Dis 67: 1689-1696.
55. Wakefield, D., McCluskey, P., Verma, M., Aziz, K., Gatus, B. and Carr, G. ( 1999) Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum 42: 1894-1897.
56. Wanders, A., Heijde, D., Landewé, R., Béhier, J.M., Calin, A., Olivieri, I. et al. (2005) Nonsteroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52: 1756-1765.
57. Yin, Z., Braun, J., Neure, L., Wu, P., Liu, L., Eggens, U. et al. (1997) Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum 40: 1788-1797.
58. Yli-Kerttula, T., Luukkainen, R., Yli-Kerttula, U., Mottonen, T., Hakola, M., Korpela, M. et al. (2000) Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 59: 565-570.
59. Yli-Kerttula, T., Luukkainen, R., Yli-Kerttula, U., Mottonen, T., Hakola, M., Korpela, M. et al. (2003) Effect of three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis 62: 880-884.